Sign of Leser-Trelat Treatment & Management

1. Turan E, Yesilova Y, Yurt N, Koçarslan S. Leser-Trélat sign: does it really exist?. Acta Dermatovenerol Croat. 2013 Aug. 21(2):123-7. [QxMD MEDLINE Link].

2. Leser E. Ueber ein die Krebskrankheit beim Menschen haufig begleitendes, noch wenig gekanntes Symptom. Munchener Med Wochenschr. 1901. 51:2035-2036.

3. De Bersaques J. Sign of Leser-Trelat. J Am Acad Dermatol. 1985. 12:724.

4. Hollander E. V. Beitrage zur Fruhdiagnose des Darmcarcinomas (Hereditatsverhaltnisse und Hautveranderungen. Deutsche Medicinische Wochenschrift. 1900. 26:483-485.

5. Dubreuilh W. Official Transactions. Des hyperkeratoses circonscrites. August 4-8, 1896.

6. Freudenthal W. Verruca senilis und Keratoma senile. Arch F Dermat U Syph (Berlin). 1926. 152:505-528.

7. Garcia RL, Bishop ME. The rapid onset of seborrheic keratoses of the breasts during pregnancy. J Assoc Mil Dermatol. 1977. 3 (2):13-4.

8. Lindelöf B, Sigurgeirsson B, Melander S. Seborrheic keratoses and cancer. J Am Acad Dermatol. 1992 Jun. 26(6):947-50. [QxMD MEDLINE Link].

9. Kilmer SL, Berman B, Morhenn VB. Eruptive seborrheic keratoses in a young woman with acromegaly. J Am Acad Dermatol. 1990 Nov. 23(5 Pt 2):991-4. [QxMD MEDLINE Link].

10. Martin RW 3rd, Rady P, Arany I, Tyring SK. Benign Leydig cell tumor of the testis associated with human papillomavirus type 33 presenting with the sign of Leser-Trelat. J Urol. 1993 Oct. 150(4):1246-50. [QxMD MEDLINE Link].

11. Inamadar AC, Palit A. Eruptive seborrhoeic keratosis in human immunodeficiency virus infection: a coincidence or 'the sign of Leser-Trelat'?. Br J Dermatol. 2003 Aug. 149(2):435-6. [QxMD MEDLINE Link].

12. Eastman KL, Knezevich SR, Raugi GJ. Eruptive seborrheic keratoses associated with adalimumab use. J Dermatol Case Rep. 2013 Jun 30. 7(2):60-3. [QxMD MEDLINE Link]. [Full Text].

13. Millard LG, Gould DJ. Hyperkeratosis of the palms and soles associated with internal malignancy and elevated levels of immunoreactive human growth hormone. Clin Exp Dermatol. 1976 Dec. 1(4):363-8. [QxMD MEDLINE Link].

14. Ellis DL, Kafka SP, Chow JC, et al. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trelat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med. 1987 Dec 17. 317(25):1582-7. [QxMD MEDLINE Link].

15. Horiuchi Y, Katsuoka K, Takezaki S, Nishiyama S. Study of epidermal growth activity in cultured human keratinocytes from peripheral-blood lymphocytes of a patient with Sezary syndrome associated with the Leser-Trelat sign. Arch Dermatol Res. 1985. 278(1):74-6. [QxMD MEDLINE Link].

16. Ellis DL, Yates RA. Sign of Leser-Trelat. Clin Dermatol. 1993 Jan-Mar. 11(1):141-8. [QxMD MEDLINE Link].

17. Ponti G, Luppi G, Losi L, Giannetti A, Seidenari S. Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. J Hematol Oncol. 2010 Jan 11. 3:2. [QxMD MEDLINE Link]. [Full Text].

18. Barron LA, Prendiville JS. The sign of Leser-Trelat in a young woman with osteogenic sarcoma. J Am Acad Dermatol. 1992 Feb. 26(2 Pt 2):344-7. [QxMD MEDLINE Link].

19. Westrom DR, Berger TG. The sign of Leser-Trelat in a young man. Arch Dermatol. 1986 Dec. 122(12):1356-7. [QxMD MEDLINE Link].

20. Narala S, Cohen PR. Cutaneous T-cell lymphoma-associated Leser-Trélat sign: report and world literature review. Dermatol Online J. 2017 Jan 15. 23 (1):[QxMD MEDLINE Link].

21. Schwengle LE, Rampen FH, Wobbes T. Seborrhoeic keratoses and internal malignancies. A case control study. Clin Exp Dermatol. 1988 May. 13(3):177-9. [QxMD MEDLINE Link].

22. Grob JJ, Rava MC, Gouvernet J, et al. The relation between seborrheic keratoses and malignant solid tumours. A case-control study. Acta Derm Venereol. 1991. 71(2):166-9. [QxMD MEDLINE Link].

23. Kierland RR. Acanthosis nigricans: an analysis of data in twenty-two cases and a study of its frequency in necropsy material. J Invest Dermatol. 1947. 9:299-305.

24. Li M, Yang LJ, Zhu XH, et al. The Leser-Trelat sign is associated with nasopharyngeal carcinoma: case report and review of cases reported in China. Clin Exp Dermatol. 2009 Jan. 34(1):52-4. [QxMD MEDLINE Link].

25. Rubisz-Brzezinska J, Zebracka T, Musialowicz D. [Coexistence of 2 paraneoplastic syndromes - acrokeratosis bazex and Leser-Trelat syndrome - in a case of squamous-cell laryngeal cancer]. Przegl Dermatol. 1983 Mar-Apr. 70(2):205-8. [QxMD MEDLINE Link].

26. Nyati A, Kalwaniya S, Jain S, Soni B. Sign of Leser-Trélat in association with laryngeal carcinoma. Indian J Dermatol Venereol Leprol. 2016 Jan-Feb. 82 (1):112. [QxMD MEDLINE Link].

27. Yavasoglu I, Kadikoylu G, Bolaman Z. The Leser-Trelat sign is a associated with acute myeloid leukemia. Ann Hematol. 2011 Mar. 90(3):363. [QxMD MEDLINE Link].

28. Fasoldt JJ, Brumwell ER, Lackey JN. Leser-Trélat sign presenting in a patient with recurrent pre-B-cell acute lymphocytic leukemia. Cutis. 2012 Jan. 89(1):33-5. [QxMD MEDLINE Link].

29. Li JH, Guo H, Li B, Gao XH. Leser-Trelat sign with primary hepatic carcinoma. Indian J Dermatol Venereol Leprol. 2015 May-Jun. 81 (3):320-1. [QxMD MEDLINE Link].

30. Onajin O, Comfere NI. Co-occurrence of malignant acanthosis nigricans and the Leser-Trélat sign in a patient with hepatocellular carcinoma. Int J Dermatol. 2015 May. 54 (5):e146-8. [QxMD MEDLINE Link].

31. Mendes GB, Zanetti G, Marchiori E. Leser-Trélat Sign Secondary to Thymic Carcinoma. Arch Bronconeumol. 2017 Nov 2. [QxMD MEDLINE Link].

32. Abakka S, Elhalouat H, Khoummane N, Achaaban M, ElAmrani S, Bargach S, et al. Uterine leiomyosarcoma and Leser-Trélat sign. Lancet. 2013 Jan 5. 381(9860):88. [QxMD MEDLINE Link].

33. Siedek V, Schuh T, Wollenberg A. Leser-Trelat sign in metastasized malignant melanoma. Eur Arch Otorhinolaryngol. 2009 Feb. 266(2):297-9. [QxMD MEDLINE Link].

34. Pereira R, Carvalho SD, Cruz JF. Leser-Trélat sign in metastatic melanoma to pleura. BMJ Case Rep. 2019 Apr 3. 12 (4):[QxMD MEDLINE Link].

35. Gori N, Esposito I, Del Regno L, D'Amore A, Peris K, Di Stefani A. Leser-Trélat sign as a rare manifestation of cutaneous melanoma. Dermatol Reports. 2020 Jun 25. 12 (1):8665. [QxMD MEDLINE Link].

36. Fink AM, Filz D, Krajnik G, Jurecka W, Ludwig H, Steiner A. Seborrhoeic keratoses in patients with internal malignancies: a case-control study with prospective accrual of patients. J Eur Acad Dermatol Venereol. 2009 Nov. 23(11):1316-9. [QxMD MEDLINE Link].

37. Siedek V, Schuh T, Wollenberg A. Leser-Trelat sign in metastasized malignant melanoma. Eur Arch Otorhinolaryngol. 2009 Feb. 266(2):297-9. [QxMD MEDLINE Link].

38. Mathez AL, Moroto D, Dib SA, de Sa JR. Seborrheic keratoses and severe hypoinsulinemic hypoglycemia associated with insulin grow factor 2 secretion by a malignant solitary fibrous tumor. Diabetol Metab Syndr. 2016. 8:33. [QxMD MEDLINE Link].

39. Stieler W, Plewig G. [Acanthosis nigricans maligna and Leser-Trélat sign in double malignancy of the breast and stomach]. Z Hautkr. 1987 Mar 1. 62(5):344-66. [QxMD MEDLINE Link].

40. Holdiness MR. A case of Leser-Trélat sign. J Am Acad Dermatol. 1987 Jan. 16(1 Pt 1):147-8. [QxMD MEDLINE Link].

41. Bedi TR. Familial congenital multiple seborrheic verrucae. Arch Dermatol. 1977 Oct. 113(10):1441-2. [QxMD MEDLINE Link].

42. Jadassohn J. Die benignen Epitheliome. Arch f Dermatol u Syph (Wien). 1913. 116:117.

43. Reiches AJ. Seborrheic keratoses; are they delayed hereditary nevi?. AMA Arch Derm Syphilol. 1952 May. 65(5):596-600. [QxMD MEDLINE Link].

44. Rongioletti F, Corbella L, Rebora A. Multiple familial seborrheic keratoses. Dermatologica. 1988. 176(1):43-5. [QxMD MEDLINE Link].

45. Dasanu CA, Alexandrescu DT. Bilateral Leser-Trelat sign mirroring lung adenocarcinoma with early metastases to the contralateral lung. South Med J. 2009 Feb. 102(2):216-8. [QxMD MEDLINE Link].

46. Janniger EJ, Schwartz RA. Florid cutaneous papillomatosis. J Surg Oncol. 2010 Nov 1. 102(6):709-12. [QxMD MEDLINE Link].

47. Jemec GB. Hypertrichosis lanuginosa acquisita. Report of a case and review of the literature. Arch Dermatol. 1986 Jul. 122(7):805-8. [QxMD MEDLINE Link].

48. Hage E, Hage J. Malignant acanthosis nigricans--a para-endocrine syndrome?. Acta Derm Venereol. 1977. 57(2):169-72. [QxMD MEDLINE Link].

49. Aylesworth R, Vance JC. Multiple hamartoma syndrome with endometrial carcinoma and the sign of Leser-Trelat. Arch Dermatol. 1982 Feb. 118(2):136-8. [QxMD MEDLINE Link].

50. Kebria MM, Belinson J, Kim R, Mekhail TM. Malignant acanthosis nigricans, tripe palms and the sign of Leser-Trelat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literature. Gynecol Oncol. 2006 May. 101(2):353-5. [QxMD MEDLINE Link].

51. Wang N, Yu PJ, Liu ZL, Zhu SM, Zhang CW. Malignant acanthosis nigricans with Leser-Trélat sign and tripe palms: A case report. World J Clin Cases. 2020 Nov 26. 8 (22):5632-5638. [QxMD MEDLINE Link].

52. da Rosa AC, Pinto GM, Bortoluzzi JS, Duquia RP, de Almeida HL Jr. Three simultaneous paraneoplastic manifestations (ichthyosis acquisita, Bazex syndrome, and Leser-Trélat sign) with prostate adenocarcinoma. J Am Acad Dermatol. 2009 Sep. 61(3):538-40. [QxMD MEDLINE Link].

53. Pembroke AC, Grice K, Levantine AV, Warin AP. Eruptive angiomata in malignant disease. Clin Exp Dermatol. 1978 Jun. 3(2):147-56. [QxMD MEDLINE Link].

54. Patton T, Zirwas M, Nieland-Fisher N, Jukic D. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat. J Drugs Dermatol. 2004 Sep-Oct. 3(5):565-6. [QxMD MEDLINE Link].

55. Peterson J, Shook BA, Wells MJ, Rodriguez M. Cupric keratosis: green seborrheic keratoses secondary to external copper exposure. Cutis. 2006 Jan. 77(1):39-41. [QxMD MEDLINE Link].

56. Pastar Z, Lipozencic J, Rados J, Stajminger G. Regressing seborrheic keratosis - clinically and dermoscopically mimicking a regressing melanoma. Acta Dermatovenerol Croat. 2007. 15(1):24-6. [QxMD MEDLINE Link].

57. Saraiya A, Al-Shoha A, Brodell RT. Hyperinsulinemia Associated with Acanthosis Nigricans, Finger Pebbles, Acrochordons, and the Sign of Leser-Trelat. Endocr Pract. 2013 Feb 20. 1-15. [QxMD MEDLINE Link].

58. Hagiwara R, Shinkuma S, Tomii K, Aizawa A, Abe R. Multiple seborrheic keratosis-like lesions of mycosis fungoides masquerading as the Leser-Trèlat sign. J Dermatol. 2020 Mar. 47 (3):e96-e97. [QxMD MEDLINE Link].

59. Schwartz RA. Acanthosis nigricans, florid cutaneous papillomatosis and the sign of Leser-Trelat. Cutis. 1981 Sep. 28(3):319-22, 326-7, 330-1 passim. [QxMD MEDLINE Link].

60. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994 Jul. 31(1):1-19; quiz 20-2. [QxMD MEDLINE Link].

61. Schwartz RA. The sign of leser-trelat. Demis DJ, ed. Clinical Dermatology. 13th ed. Philadelphia, Pa: JB Lippincott; 1987. 26A: 1-3.

62. Schwartz RA. Florid cutaneous papillomatosis. Clin Dermatol. 1993 Jan-Mar. 11(1):89-91. [QxMD MEDLINE Link].

63. Schwartz RA. Sign of Leser-Trelat. J Am Acad Dermatol. 1996 Jul. 35(1):88-95. [QxMD MEDLINE Link].

64. Schwartz RA, Burgess GH. Florid cutaneous papillomatosis. Arch Dermatol. 1978 Dec. 114(12):1803-6. [QxMD MEDLINE Link].

65. Schwartz RA, Helmold ME, Janniger CK, Gascon P. Sign of Leser-Trelat with a metastatic mucinous adenocarcinoma. Cutis. 1991 Apr. 47(4):258-60. [QxMD MEDLINE Link].

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Professor of Pediatrics, Professor of Medicine, Rutgers New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, New York Academy of Medicine, Royal College of Physicians of Edinburgh, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

David F Butler, MD Former Section Chief of Dermatology, Central Texas Veterans Healthcare System; Professor of Dermatology, Texas A&M University College of Medicine; Founding Chair, Department of Dermatology, Scott and White Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Association of Military Dermatologists, Phi Beta Kappa, Texas Dermatological Society

Disclosure: Nothing to disclose.

Warren R Heymann, MD Head, Division of Dermatology, Professor, Department of Internal Medicine, Rutgers New Jersey Medical School

Warren R Heymann, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Takeji Nishikawa, MD Emeritus Professor, Department of Dermatology, Keio University School of Medicine; Director, Samoncho Dermatology Clinic; Managing Director, The Waksman Foundation of Japan Inc

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article